Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary

Anticancer Research

Volumn 27, Issue 4 C, 2007, Pages 2931-2937

  Kiss, István ^a   Orsós, Zsuzsa ^a   Gombos, Katalin ^a   Bogner, Barna ^b   Csejtei, András ^c   Tibold, Antal ^a   Varga, Zsuzsa ^b   Pázsit, Emese ^d   Magda, Ingrid ^a   Zólyomi, Annamária ^a   Ember, István ^a  

^a UNIVERSITY OF PÉCS   (Hungary)

^b Baranya County Hospital   (Hungary)

^c Markusovszky Teaching Hospital   (Hungary)

^d Diósgyor Hospital   (Hungary)

Author keywords

Colorectal cancer; CYP 1A1; CYP 1A2; CYP 2E1; Genetic polymorphism; mEH

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1A2; CYTOCHROME P450 2E1; EPOXIDE HYDROLASE;

ALLELE; ARTICLE; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DNA POLYMORPHISM; EXON; GENOTYPE; HUMAN; HUNGARY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE;

ALLELES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; CYTOCHROME P-450 ENZYME SYSTEM; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HUNGARY; ISOENZYMES; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 34547769925     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Vainio H and Miller AB: Primary and secondary prevention in colorectal cancer. Acta Oncologica 42: 809-815, 2003.
2. Hawk ET, Limburg PJ and Viner JL: Epidemiology and prevention of colorectal cancer. Surg Clin N Amer 82: 905-941, 2002.
3. Lewis DF: P450 structures and oxidative metabolism of xenobiotics. Pharmacogenomics 4: 387-395, 2003.
4. Sheweita SA: Drug-metabolizing enzymes: mechanisms and functions. Curr Drug Metab 1: 107-132, 2000.
5. Le Marchand L, Guo C, Benhamou S et al: Pooled analysis of the CYP1A1 exon 7 polymorphism and lung cancer (United States). Cancer Causes Control 14: 339-346, 2003.
6. Hung RJ, Boffetta P, Brockmoller J et al: CYP1A1 and GSTM1 genetic polymorphisms and lung cancer risk in Caucasian non-smokers: a pooled analysis. Carcinogenesis 24: 875-882, 2003.
7. Watanabe M: Polymorphic CYP genes and disease predisposition - what have the studies shown so far? Toxicol Lett 102-103: 167-171, 1998.
8. Kiyohara C, Hirohata T and Inutsuka S: The relationship between aryl hydrocarbon hydroxylase and polymorphisms of the CYP1A1 gene. Jpn J Cancer Res 87: 18-24, 1996.
9. Eaton DL, Gallagher EP, Bammler TK and Kunze KL: Role of cytochrome P450 1A2 in chemical carcinogenesis: implications for human variability in expression and enzyme activity. Pharmacogenetics 5: 259-274, 1995.
10. Obase Y, Shimoda T, Kawano T et al: Polymorphisms in the CYP1A2 gene and theophylline metabolism in patients with asthma. Clin Pharmacol Ther 73: 468-474, 2003.
11. Sachse C, Brockmoller J, Bauer S and Roots I: Functional significance of a C->A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 47: 445-449, 1999.
12. Sachse C, Bhambra U, Smith G et al: Polymorphisms in the cytochrome P450 CYP1A2 gene (CYP1A2) in colorectal cancer patients and controls: allele frequencies, linkage disequilibrium and influence on caffeine metabolism. Br J Clin Pharmacol 55: 68, 2003.
13. Tanaka E, Terada M and Misawa S: Cytochrome P450 2E1: its clinical and toxicological role. J Clin Pharm Ther 25: 165-175, 2000.
14. Poschl G, Stickel F, Wang XD et al: Alcohol and cancer: genetic and nutritional aspects. Proc Nutr Soc 63: 65-71, 2004.
15. Bartsch H, Nair U, Risch A et al: Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers. Cancer Epidemiol Biomarkers Prev 9: 3-28, 2000.
16. Wu MS, Chen CJ, Lin MT et al: Genetic polymorphisms of cytochrome p450 2E1, glutathione S-transferase M1 and T1, and susceptibility to gastric carcinoma in Taiwan. Int J Colorectal Dis 17: 338-343, 2002.
17. Verlaan M, Te Morsche RH, Roelofs HM et al: Genetic polymorphisms in alcohol-metabolizing enzymes and chronic pancreatitis. Alcohol Alcoholism 39: 20-24, 2004.
18. Lee WJ, Brennan P, Boffetta P et al: Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review. Biomarkers 7: 230-241, 2002.
19. Hassett C, Aicher L, Sidhu JS et al: Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3: 421-428, 1994.
20. Ulrich CM, Bigler J, Whitton JA et al: Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev 10: 875-882, 2001.
21. Harrison DJ, Hubbard AL, MacMillan J et al: Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer 79: 168-171, 1999.
22. Blin N and Stafford DW: A general method for isolation of high molecular weight DNA from eukaryotes. Nucleic Acids Res 3: 2303-2308, 1976.
23. Suzuki S, Muroishi Y, Nakanishi I et al: Relationship between genetic polymorphisms of drug-metabolizing enzymes (CYP1A1, CYP2E1, GSTM1, and NAT2), drinking habits, histological subtypes, and p53 gene point mutations in Japanese patients with gastric cancer. J Gastroenterol 39: 220-230, 2004.
24. Yin L, Pu Y, Liu TY et al: Genetic polymorphisms of NAD(P)H quinone oxidoreductase, CYP 1A 1 and microsomal epoxide hydrolase and lung cancer risk in Nanjing, China. Lung Cancer 33: 133-141, 2001.
25. Martinez ME: Primary prevention of colorectal cancer: lifestyle, nutrition, exercise. Recent Results Cancer Res 166: 177-211, 2005.
26. Sinha R, Peters U, Cross AJ et al: Meat, meat cooking methods and preservation, and risk for colorectal adenoma. Cancer Res 65: 8034-8041, 2005.
27. Ahmed FE: Effect of diet, life style, and other environmental/ chemopreventive factors on colorectal cancer development, and assessment of the risks. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 22: 91-147, 2004.
28. Thier R, Bruning T, Roos PH et al: Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes. Int J Hygiene Environ Health 206: 149-171, 2003.
29. Zhang J, Ichiba M, Feng Y et al: Aromatic DNA adducts in coke-oven workers,in relation to exposure, lifestyle and genetic polymorphism of metabolic enzymes. Int Arch Occup Environ Health 73: 127-135, 2000.
30. Sivaraman L, Leatham MP, Yee J et al: CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Res 54: 3692-3695, 1994.
31. Ye Z and Parry JM: Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer. Teratog Carcinog Mutagen 22: 385-392, 2002.
32. Kiss I, Sandor J, Pajkos G et al: Colorectal cancer risk in relation to genetic polymorphism of cytochrome P450 1A1, 2E1, and glutathione-S-transferase M1 enzymes. Anticancer Res 20: 519-522, 2000.
33. Butler WJ, Ryan P and Roberts-Thomson IC: Metabolic genotypes and risk for colorectal cancer. J Gastroenterol Hepatol 16: 631-635, 2001.
34. Ishibe N, Stampfer M, Hunter DJ et al: A prospective study of cytochrome P450 1A1 polymorphisms and colorectal cancer risk in men. Cancer Epidemiol Biomarkers Prev 9: 855-856, 2000.
35. Sachse C, Smith G, Wilkie MJV et al: A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis 23: 1839-1849, 2002.
36. Slattery ML, Samowtiz W, Ma K et al: CYP1A1, cigarette smoking, and colon and rectal cancer. Am J Epidemiol 160: 842-852, 2004.
37. Murtaugh MA, Sweeney C, Ma K et al: The CYP1A1 genotype may alter the association of meat consumption patterns and preparation with the risk of colorectal cancer in men and women. J Nutr 135: 179-186, 2005.
38. Landi S, Gemignani F, Moreno V et al: A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of colorectal cancer. Pharmacogenet Genomics 15: 535-546, 2005.
39. Yu WP, Chen K, Ma XY et al: Genetic polymorphism in cytochrome P450 2E1, salted food and colorectal cancer susceptibility: a case-control study. Zhonghua Yu Fang Yi Xue Za Zhi 38: 162-166, 2004.
40. Le Marchand L, Donlon T, Seifried A et al: Red meat intake, CYP2E1 genetic polymorphisms, and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1019-1024, 2002.
41. Moonen H, Engels L, Kleinjans J et al: The CYP1A2-164A/C polymorphism (CYP1A2*1F) is associated with the risk for colorectal adenomas in humans. Cancer Lett 229: 25-31, 2005.
42. Le Marchand L, Hankin JH, Pierce LM et al: Well-done red meat, metabolic phenotypes and colorectal cancer in Hawaii. Mutation Res 506-507: 205-214, 2002.
43. Hein DW, Doll MA, Fretland AJ et al: Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 9: 29-42, 2000.
44. Kiyohara C, Otsu A, Shirakawa T et al: Genetic polymorphisms and lung cancer susceptibility: a review. Lung Cancer 37: 241-256, 2002.
45. van der Logt EM, Bergevoet SM, Roelofs HM et al: Role of epoxide hydrolase, NAD(P)H:quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. Mutat Res 593: 39-49, 2006.
46. Turner F, Smith G, Sachse C et al: Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer. Int J Cancer 112: 259-264, 2004.
47. Cortessis V, Siegmund K, Chen Q et al: A case-control study of microsomal epoxide hydrolase, smoking, meat consumption, glutathione S-transferase M3, and risk of colorectal adenomas. Cancer Res 61: 2381-2385, 2001.
48. Tranah GJ, Giovannucci E, Ma J et al: Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study. Carcinogenesis 25: 1211-1218, 2004.
49. Huang WY, Chatterjee N, Chanock S et al: Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma. Cancer Epidemiol Biomarkers Prev 14: 152-157, 2005.